HIGHLIGHTS
- who: Dimitrios Patoulias et al. from the University of Thessaloniki, Thessaloniki, Greece have published the paper: Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study, in the Journal: Medicina 2022, 1167 of /2022/
- what: The authors aimed at determining the effect of two different sodiumglucose co-transporter-2 (SGLT-2) inhibitors on ambulatory arterial stiffness in individuals with T2DM.
- how: Concerning other indices of arterial stiffness the authors showed that the SGLT-2 inhibitor This is the first . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.